pillbase.ru

Carbaglu

Active substance: carglumic acid

TABLET, FOR SUSPENSION · CARGLUMIC ACID 200 mg/1

United StatesActive

Marketing holder: Recordati Rare Diseases

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Carbaglu
    carglumic acid
    EMEA/H/C/000461
    Tour Hekla
  • Ucedane
    carglumic acid
    EMEA/H/C/004019
    Eurocept International BV
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-7270-7f29-a3bd-40938620752d,01a1208d-8f51-7296-a381-325f69d8b81c,01a1208d-b6fa-73f1-8dea-02b00279412f,01a1209a-d00d-79b8-82bc-553f0803e024;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
52276-312
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 52276-312 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 52276-312 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 52276-312 · Verified 2026-10-09 · open in source